The purpose of this study is to identify prognostic parameters about efficacy of Mesalazine in recently diagnosed patients with Morbus Crohn by retrospective data collection.
Study Type
OBSERVATIONAL
Enrollment
161
Investigational Site, Ehrenfelsstraße 47
Berlin, Germany
Investigational Site, Möllendorfstraße 111
Berlin, Germany
Investigational Site, Graseggerstraße 105
Response to Mesalazine: measured by time to step up therapy
Time frame: 12 to 48 months
Identification and characterisation of the responding sub-population
measured by: (a) Age at diagnosis, (b) Proportion of patients with minor endoscopic lesions, (c) Lack of severe mucosal lesions (Adapted Rutgeerts Score \< 2)
Time frame: 12 to 48 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cologne, Germany
Investigational Site, Münchner Straße 64
Dachau, Germany
Investigational Site, Karlsbader Straße 7
Dinkelsbühl, Germany
Investigational Site, Heiligengrabstraße 16
Hof, Germany
Investigational Site, Am Tiefen Weg 2
Karlstadt am Main, Germany
Investigational Site, Erdbeerfeld 8
Kiel-Altenholz, Germany
Investigational Site, Hohenfelder Straße 20
Koblenz, Germany
Investigational Site, Funkenburgstraße 19
Leipzig, Germany
...and 6 more locations